
Reset all filters
01 2Allergan Pharmaceuticals International Limited
02 2Allergan Pharmaceuticals Ireland
03 2PIERRE FABRE ITALIA SpA
Reset all filters
01 2Tazaroten
02 4Tazarotene
Reset all filters
01 4Gel
02 1Tazarotene 0.05% 15G Gel Dermatological Use
03 1Tazarotene 0.1% 15G Gel Dermatological Use
Reset all filters
01 2Italy
02 2Spain
03 2Sweden
Reset all filters
01 4Zorac
02 1Zorac 0.05% Gel
03 1Zorac 0.1% Gel
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Zorac
Dosage Form : Gel
Dosage Strength : 0.0005
Packaging :
Approval Date : 22/08/1997
Application Number : 19970822000077
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Zorac
Dosage Form : Gel
Dosage Strength : 0.10%
Packaging :
Approval Date : 22/08/1997
Application Number : 19970822000084
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Zorac 0.1% Gel
Dosage Form : Gel
Dosage Strength : 0.1%
Packaging :
Approval Date : 1998-07-01
Application Number : 61861
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Zorac 0.05% Gel
Dosage Form : Gel
Dosage Strength : 0.05%
Packaging :
Approval Date : 1998-07-01
Application Number : 61862
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info :
Registration Country : Italy
Brand Name : Zorac
Dosage Form : Tazarotene 0.05% 15G Gel Dermatological Use
Dosage Strength : gel derm 15 g 0.05%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Zorac
Dosage Form : Tazarotene 0.1% 15G Gel Dermatological Use
Dosage Strength : gel derm 15 g 0,1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy